Biotech 2050 Podcast

Exploring Neuroscience, Psychiatry, & Rare Diseases, Bruce Leuchter, President & CEO, Neurvati

Transformative Oncology Innovations, Ken Keller, President & CEO, Daiichi Sankyo

Strategic Leadership and Autoimmune Breakthroughs, Praveen Tipimeni, CEO

Innovative Approaches to Cancer Therapies, Robert Ang, President and CEO

Tech-Biotech Convergence, Growth, and Global Lessons, Vik Bajaj, Co-founder and CEO

The convergence of technology and biotechnology is fundamentally transforming drug development and healthcare delivery by leveraging large-scale datasets and machine learning to personalize patient care. Vik Bajaj, Managing Director of Foresight Capital Management and CEO of Foresight Labs, highlights how data-driven a...

Advancing and Revolutionizing Sickle Cell Treatment, Ted Love, Chair and BOD

Demystifying Drug Discovery, Ray Stevens, CEO, Structure Therapeutics

Navigating The Evolving Landscape of Inflammation Research, Scott Megaffin, CEO, Adiso Therapeutics

Biotech's Game Changers & Revolutionizing Therapeutics, Dr. Mammen, CEO, FogPharma

The Race to Cure Untreatable Cancers, Ken Galbraith, Chair and CEO, Zymeworks

Innovation in Precision Therapies for CNS Diseases, Craig Chambliss, Co-Founder and CEO, Neurelis

Unlocking Genetic Medicine's Full Potential, Tuyen Ong, CEO, Ring Therapeutics

Aging Biology and The Power of Human Data, Kristen Fortney, Co-Founder and CEO, BioAge

The Intersection Of Tech and Biotech, Chris Gibson, Co-Founder & CEO, Recursion

Biotech 2050 Apieron Investment Episode

Navigating Platform vs Product Tension, David Kirn, Co-Founder & CEO, 4DMT

Adapting Through Disruption in Biotech, David Esposito, President & CEO, ONL Therapeutics

Overcoming Capital Challenges in Biotech, Jak Knowles, President & CEO, Affini-T Therapeutics

A novel approach to advancing breast cancer therapy, Sean Bohen, President & CEO, Olema Oncology

The promise of precision oncology, Troy Wilson, President & CEO, Kura Oncology